Budd-Chiari syndrome in small hepatic veins: A diagnostic and therapeutic challenge in a low resource setting

Introduction: Budd-Chiari syndrome (BCS) is a rare condition affecting one in a million adults. BCS involves outflow obstruction in the hepatic venous system, which can occur anywhere between the small hepatic veins and the atrio-caval junction and cannot be due to heart, pericardial, or hepatic veno-occlusive disease. Case Presentation: We report an exceedingly rare form of BCS with less common initial clinical features in a young poor adult male patient which ignited a diagnostic uncertainty and a therapeutic challenge. The presence of the classical triad of BCS in the absence of major hepatic vein obstruction prompted the medical team to consider that the patient had a rare form of BCS. In this case, the financial condition of the patient and limited resources available restricted our ability to advance into the specific investigations. However, the patient was given symptomatic medical treatment and was followed up monthly. We also provided the patient with a statement that reaffirmed our inability to provide affordable surgical management options and called for an optimized national clinical guideline that could help the physicians deal with the challenges. Conclusion: An uncommon form of BCS in this patient provided a diagnostic challenge and therapeutic uncertainty in the low-resource settings. Primary care physicians should commence evidenced medical management based on clinical suspicion acknowledging the fact that obstruction of small hepatic veins is often not detected on an ultrasound.

[1]  V. De Stefano,et al.  Epidemiology of Budd-Chiari syndrome: A systematic review and meta-analysis. , 2019, Clinics and research in hepatology and gastroenterology.

[2]  Varun Bansal,et al.  Budd-Chiari syndrome: imaging review. , 2018, The British journal of radiology.

[3]  Hwa Young Choi,et al.  Incidence, prevalence and complications of Budd–Chiari syndrome in South Korea: a nationwide, population‐based study , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[4]  D. Valla,et al.  Small hepatic veins Budd–Chiari syndrome , 2013, Journal of Thrombosis and Thrombolysis.

[5]  E. Björnsson,et al.  Budd‐Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival – an 18‐year experience , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[6]  A. Plessier,et al.  Budd-Chiari Syndrome , 2008, La Revue de medecine interne.

[7]  J. Horton,et al.  Budd–Chiari syndrome: illustrated review of current management , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[8]  A. Pithawa,et al.  Sleisenger and Fordtran's Gastrointestinal and Liver Disease: pathophysiology, diagnosis, management , 2007 .

[9]  G. Mufti,et al.  Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. , 2005, Gastroenterology.

[10]  D. Valla,et al.  EASL Clinical Practice Guidelines: Vascular diseases of the liver. , 2016, Journal of hepatology.

[11]  H. Janssen,et al.  Vascular liver disorders (I): diagnosis, treatment and prognosis of Budd-Chiari syndrome. , 2008, The Netherlands journal of medicine.

[12]  A. Pezzella,et al.  Membranous obstruction of hepatic venous flow. , 1995, Texas Heart Institute journal.